Oxford Pharmascience Group Plc | Medicines made better

 

News

22 November 2017

Holding(s) in Company

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)
 
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Oxford Pharmascience Group plc
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer X
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments  
An event changing the breakdown of voting rights  
Other (please specify):  
3. Details of person subject to the notification obligation
Name Richard Griffiths and family
City and country of registered office (if applicable) St Helier, Jersey
4. Full name of shareholder(s) (if different from 3.)
Name  
City and country of registered office (if applicable)  
5. Date on which the threshold was crossed or reached: 20 November 2017
6. Date on which issuer notified (DD/MM/YYYY): 22 November 2017
7. Total positions of person(s) subject to the notification obligation
  % of voting rights attached to shares
(total of 8. A)
% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)
Total of both in %
(8.A + 8.B)
Total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed or reached 22.74% 0.00% 22.74% 1,205,661,619
Position of previous notification (if applicable) 14.18% 0.00% 14.18%  

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
A: Voting rights attached to shares
Class/type of
shares
ISIN code (if possible)
Number of voting rights % of voting rights
Direct
(Art 9 of Directive 2004/109/EC)
(DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC)
(DTR5.2.1)
Direct
(Art 9 of Directive 2004/109/EC)
(DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC)
(DTR5.2.1)
Ordinary
GB00B3LXPB43
274,170,782 0 22.74% 0.00%
         
         
SUBTOTAL 8. A 274,170,782 22.74%

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument Expiration
date
Exercise/
Conversion Period
Number of voting rights that may be acquired if the instrument is exercised/converted. % of voting rights
         
         
         
    SUBTOTAL 8. B 1    

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument Expiration
date
Exercise/
Conversion Period
Physical or cash settlement Number of voting rights % of voting rights
           
           
           
      SUBTOTAL 8.B.2    

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer  
Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)
X
Name % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold
Richard Griffiths and family 3.67% 0.00% 3.67%
Blake Holdings Limited 14.97% 0.00% 14.97%
Cream Capital Limited 3.49% 0.00% 3.49%
Other Holdings below the the 3% threshold 0.62% 0.00% 0.62%

10. In case of proxy voting, please identify:
Name of the proxy holder NA
The number and % of voting rights held NA
The date until which the voting rights will be held NA

11. Additional information
 

Place of completion St Helier, Jersey
Date of completion 22 November 2017

 

back to top